Financhill
Back

Actinium Pharmaceuticals 10K Form

Sell
50

ATNM
Actinium Pharmaceuticals

Last Price:
5.67
Seasonality Move:
3.07%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive ATNM News And Ratings

See the #1 stock for the next 7 days that we like better than ATNM

ATNM Financial Statistics

Sales & Book Value

Annual Sales: $1.14M
Cash Flow: $-5.79M
Price / Cash Flow: 0
Annual Sales: $3.11
Price / Book: 1.89

Profitability

EPS (TTM): -1.14000
Net Income (TTM): $-24.58M
Gross Margin: $0
Return on Equity: -32.87%
Return on Assets: -30.81%

Actinium Pharmaceuticals Earnings Forecast

Key Actinium Pharmaceuticals Financial Ratios

  • The Selling, General & Administrative Expenses for ATNM have been equal to 708.77% of Gross Profit Margin.
  • The Research & Development expenses have been 1,581.58% of Revenue.
  • The Interest Expense is -0.04% of Operating Income.
  • Per Share Earnings over the last 16 years have been positive in 9 years.

Actinium Pharmaceuticals Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYAM
Industry: Biotechnology
Sector: Healthcare
Current Symbol: ATNM
CUSIP: 00507W
Website: actiniumpharma.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 12.94
Quick Ratio: 12.58

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

ATNM Technical Analysis vs Fundamental Analysis

Sell
50
Actinium Pharmaceuticals (ATNM) is a Sell

Is Actinium Pharmaceuticals a Buy or a Sell?